"/> Novus Biologicals™ Peptide bloquant d’anticorps AA… | B-LABO France

Novus Biologicals™ Peptide bloquant d’anticorps AATF

Réf. : BL-RE-142660Réf. fabricant : 18279965 0.05 mg
201,94 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
26574
Espèces
Human
Contenu et stockage
Store at -20 C. Avoid freeze-thaw cycles.
Formule
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)
This Peptide is Useful as a Blocking Peptide for NBP1-76655. For Further Blocking Peptide Related Protocol, Click Here .
Marque
Novus Biologicals

A blocking peptide containing 12 amino acids near the carboxy terminus of human AATF.

Points forts

Source

Synthetic

(Accession #: NP_036270) The AATF Blocking Peptide has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-142660
Réf. fabricant18279965
Gene ID (Entrez)26574
EspècesHuman
Contenu et stockageStore at -20 C. Avoid freeze-thaw cycles.
FormulePBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)This Peptide is Useful as a Blocking Peptide for NBP1-76655. For Further Blocking Peptide Related Protocol, Click Here .
Alias de gèneapoptosis antagonizing transcription factor, Apoptosis-antagonizing transcription factor, CHE-1, CHE1Rb-binding protein Che-1, DEDprotein AATF
Symbole de gène(s)AATF
Type de produitAATF
Quantité0.05 mg
État réglementaireRUO - research use only
SourceSynthetic
Consigne12 amino acids near the carboxy terminus of human AATF
Une question, une configuration particulière ?
Contactez-nous pour un devis.